Pharma

Your Article Summary

See Latest Articles

Taro Receives FDA Approval for Levetiracetam Oral Solution
Taro Pharmaceuticals USA, 02/12/09

Taro Pharmaceutical Industries Ltd. reported that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levetiracetam Oral Solution, 100 mg/mL.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

 See all of Drug/Product Approvals